Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1836780rdf:typepubmed:Citationlld:pubmed
pubmed-article:1836780lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1836780lifeskim:mentionsumls-concept:C0036508lld:lifeskim
pubmed-article:1836780lifeskim:mentionsumls-concept:C0022625lld:lifeskim
pubmed-article:1836780lifeskim:mentionsumls-concept:C0014020lld:lifeskim
pubmed-article:1836780pubmed:issue11lld:pubmed
pubmed-article:1836780pubmed:dateCreated1992-2-4lld:pubmed
pubmed-article:1836780pubmed:abstractTextFifty patients (42 men, 8 women) with seborrheic dermatitis were included in the trial. Ketoconazole 2% emulsion or the same emulsion without active drug was applied b.i.d. for 4 weeks. Two patients dropped out in the ketoconazole group and nine in the placebo group. Pityrosporum ovale was cultured from all patients at the start and from six out of 23 in the ketoconazole group versus nine out of 16 in the placebo group at week 4. The overall assessment showed a significantly better response to treatment for the ketoconazole emulsion (72%) than for the placebo (32%).lld:pubmed
pubmed-article:1836780pubmed:languageenglld:pubmed
pubmed-article:1836780pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1836780pubmed:citationSubsetIMlld:pubmed
pubmed-article:1836780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1836780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1836780pubmed:statusMEDLINElld:pubmed
pubmed-article:1836780pubmed:monthNovlld:pubmed
pubmed-article:1836780pubmed:issn0011-9059lld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:PiérardG EGElld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:Van CutsemJJlld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:Piérard-Franc...lld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:RurangirwaAAlld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:Hoppenbrouwer...lld:pubmed
pubmed-article:1836780pubmed:authorpubmed-author:SchrootenPPlld:pubmed
pubmed-article:1836780pubmed:issnTypePrintlld:pubmed
pubmed-article:1836780pubmed:volume30lld:pubmed
pubmed-article:1836780pubmed:ownerNLMlld:pubmed
pubmed-article:1836780pubmed:authorsCompleteYlld:pubmed
pubmed-article:1836780pubmed:pagination806-9lld:pubmed
pubmed-article:1836780pubmed:dateRevised2006-10-30lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:meshHeadingpubmed-meshheading:1836780-...lld:pubmed
pubmed-article:1836780pubmed:year1991lld:pubmed
pubmed-article:1836780pubmed:articleTitleKetoconazole 2% emulsion in the treatment of seborrheic dermatitis.lld:pubmed
pubmed-article:1836780pubmed:affiliationDepartment of Dermatopathology, CHU du Sart Tilman, Liege, Belgium.lld:pubmed
pubmed-article:1836780pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1836780pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1836780pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1836780lld:pubmed